Cancer Risk in Polycystic Ovary Syndrome Patients: Common Treatments and Future Perspectives

    June 2023 in “ Journal of multidisciplinary sciences ”
    Alfi Shahrin, Mahmuda Akter Mele, Mohammad Zahirul Islam
    Image of study
    TLDR PCOS may increase the risk of certain cancers.
    Polycystic ovarian syndrome (PCOS) is a prevalent endocrine and metabolic disorder in women of childbearing age, characterized by ovulatory dysfunction, hyperandrogenism, and multiple cystic ovaries. PCOS is associated with symptoms such as pattern hair loss, acne, obesity, infertility, and hirsutism, often stemming from an unhealthy lifestyle, genetic factors, androgen exposure, and neuroendocrine influences. These factors lead to hormonal imbalances, hyperandrogenism, high insulin levels, and inflammation. This review explores the debated link between PCOS and increased cancer risk, particularly reproductive cancers, and investigates the underlying causes of cancer in PCOS patients.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community DHT levels after 4 weeks of Fina and 8 weeks of Fina + 4 weeks of Duta

      in Update  34 upvotes 6 years ago
      The user reported early stage diffuse hair thinning and increased DHT levels after 4 weeks on Finasteride and 8 weeks on Finasteride plus 4 weeks on Dutasteride, despite the medications being authentic and stored properly. They are considering increasing their Dutasteride dosage due to the lack of side effects and are unsure if the treatment is helping their hair.

      community Balding without a family history

      in Chat  6 upvotes 2 weeks ago
      The user is experiencing hair loss without a family history and suspects stress or telogen effluvium (TE) as the cause, despite using finasteride without results. Others suggest stress, vitamin deficiencies, or other conditions could be factors, and some mention that balding can occur without a family history.

      community Spironolactine Update: 2 months (34, Female)

      in Female  22 upvotes 8 years ago
      A female user's experience using Spironolactone to treat Female Pattern Hair Loss (FPHL) and Androgenic Alopecia, as well as discussing the effectiveness of the drug at different dosages.

      community Quit vaping/smoking = 80% less loss

      in Research/Science  235 upvotes 1 year ago
      Quitting vaping significantly reduced hair loss for a user who was a heavy vaper and also taking finasteride. Some participants suggest nicotine's vasoconstrictive properties may worsen hair loss, while others share personal anecdotes of hair improvement after quitting smoking or vaping.

    Related Research

    5 / 5 results